Thermo Fisher Scientific Inc.
NYSE-TMO
Company Overview
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Name
Thermo Fisher Scientific Inc.
CEO
Mr. Marc N. Casper
Website
www.thermofisher.com
Sector
Life Sciences Tools and Services
Year Founded
1956
Profile
Market Cap
$234.6B
EV
$261.31B
Shares Out
382M
Revenue
$42.35B
Employees
122,000
Margins
Gross
40.69%
EBITDA
25.42%
Operating
17.58%
Pre-Tax
16.01%
Net
14.69%
FCF
18.8%
Returns (5Yr Avg)
ROA
8.2%
ROTA
29.03%
ROE
16.81%
ROCE
11.71%
ROIC
10.85%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
$642.56
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
$8,823M
Net Debt
$26.6B
Debt/Equity
0.75
EBIT/Interest
5.1
Growth (CAGR)
Rev 3Yr
3.45%
Rev 5Yr
11.23%
Rev 10Yr
11.02%
Dil EPS 3Yr
-9.27%
Dil EPS 5Yr
12.99%
Dil EPS 10Yr
15.41%
Rev Fwd 2Yr
3.19%
EBITDA Fwd 2Yr
3.79%
EPS Fwd 2Yr
5.47%
EPS LT Growth Est
9.45%
Dividends
Yield
—
Payout
9.14%
DPS
$1.48
DPS Growth 3Yr
15.52%
DPS Growth 5Yr
15.5%
DPS Growth 10Yr
9.45%
DPS Growth Fwd 2Yr
6.04%